Table 1.
Baseline characteristics
| Characteristics | GT n=30 | ST n=30 | p value |
|---|---|---|---|
| Age | 5.5 (4-10.2) | 5 (4-9.2) | 0.70 |
| Gender | 0.59 | ||
| Male | 18 (60%) | 21 (70%) | |
| Female | 12 (40%) | 9 (30%) | |
| Primary diagnosis | |||
| Hematological malignancies | |||
| ALL | 10 (33.3%) | 14 (46.7%) | 0.54 |
| AML | 6 (20%) | 7 (23.3%) | |
| ALL relapse | 3 (10%) | 1 (3.3%) | |
| AML relapse | 1 (3.3%) | 1 (3.3%) | |
| Lymphomas | 3 (10%) | 5 (16.7%) | |
| Solid tumors | |||
| Retinoblastoma | 1 (3.3%) | 1 (3.3%) | |
| Ewing’s sarcoma | 4 (13.3%) | 1 (3.3%) | |
| Others | 2 (6.7%) | 0 | |
| Focus of infection | |||
| Respiratory | 10 (33%) | 10 (33%) | 0.21 |
| GI | 17 (57%) | 11 (37%) | |
| Both | 0 | 1 (3%) | |
| No focus | 3 (10%) | 8 (27%) | |
| CXR abnormality at admission | 2 (7.1%) | 4 (14.3%) | 0.67 |
| Total febrile period before admission (days) | 3 (1-5.2) | 3 (1-7) | 0.32 |
| Antibiotic received before admission | |||
| No antibiotics | 13 (43.3%) | 14 (46.7%) | 0.90 |
| First line antibiotics | 4 (13.3%) | 4 (13.3%) | |
| Second line antibiotics | 12 (40%) | 10 (30.3%) | |
| Empirical Antifungals | 1 (3.3%) | 2 (6.7%) |
Categorical variables were compared using Chi-square test and continuous variables using Mann-Whitney U test.